 |
|
|
| |
Efruxifermin was associated with improvements in multiple non-invasive tests indicative of fibrosis regression in participants with compensated cirrhosis due to MASH (SYMMETRY)
|
| |
| |
AASLD 2025 Nov 7-11 Wash DC
Co-Author(s)
Arun Sanyal, Guy Neff, Doreen Chan, Mark Burch, Erik Tillman, Sonja Billes, Arian Zari, Dragan Mackovic, Brittany De Temple, Reshma Shringarpure, Meena Jain, Timothy Rolph, Andrew Cheng, Kitty Yale, Mazen Noureddin
Presenting Author(s)
Vlad Ratziu
|
| |
|
|
|
|
|
